These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30053818)

  • 1. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of apolipoprotein A5 in obesity and the metabolic syndrome.
    Zheng XY; Zhao SP; Yan H
    Biol Rev Camb Philos Soc; 2013 May; 88(2):490-8. PubMed ID: 23279260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes.
    Zheng XY; Yu BL; Xie YF; Zhao SP; Wu CL
    Mol Med Rep; 2017 Nov; 16(5):6771-6779. PubMed ID: 28901468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A5 internalized by human adipocytes modulates cellular triglyceride content.
    Zheng XY; Zhao SP; Yu BL; Wu CL; Liu L
    Biol Chem; 2012 Mar; 393(3):161-7. PubMed ID: 22718631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into Apolipoprotein A5 and the Modulation of Human Adipose-derived Mesenchymal Stem Cells Adipogenesis.
    Su X; Weng S; Peng D
    Curr Mol Med; 2020; 20(2):144-156. PubMed ID: 31560287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
    Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
    Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.
    Garelnabi M; Lor K; Jin J; Chai F; Santanam N
    Clin Biochem; 2013 Jan; 46(1-2):12-9. PubMed ID: 23000317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
    Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
    Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.
    Li R; Chen LZ; Zhao W; Zhao SP; Huang XS
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1173-8. PubMed ID: 27544029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.
    Bertoccini L; Sentinelli F; Incani M; Bailetti D; Cimini FA; Barchetta I; Cavallo MG; Cossu E; Lenzi A; Loche S; Baroni MG
    Lipids Health Dis; 2017 Sep; 16(1):179. PubMed ID: 28927406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exchangeable apolipoproteins in lipid metabolism and obesity.
    Su X; Peng D
    Clin Chim Acta; 2020 Apr; 503():128-135. PubMed ID: 31981585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.
    Hubacek JA
    Gene; 2016 Oct; 592(1):193-199. PubMed ID: 27496343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population.
    Kefi R; Hechmi M; Dallali H; Elouej S; Jmel H; Halima YB; Nagara M; Chargui M; Fadhel SB; Romdhane S; Kamoun I; Turki Z; Abid A; Bahri S; Bahlous A; Gomis R; Baraket A; Grigorescu F; Normand C; Jamoussi H; Abdelhak S
    Ann Endocrinol (Paris); 2017 Jul; 78(3):146-155. PubMed ID: 28624160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses.
    Ibi D; Boot M; Dollé MET; Jukema JW; Rosendaal FR; Christodoulides C; Neville MJ; Koivula R; Rensen PCN; Karpe F; Noordam R; Willems van Dijk K
    J Lipid Res; 2022 May; 63(5):100193. PubMed ID: 35278410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.
    Dai W; Zhang Z; Yao C; Zhao S
    Lipids Health Dis; 2019 Dec; 18(1):220. PubMed ID: 31836003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism.
    Forte TM; Ryan RO
    Curr Drug Targets; 2015; 16(12):1274-80. PubMed ID: 26028042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A5, a unique modulator of fasting and postprandial triglycerides.
    May-Zhang L; Liu M; Black D; Tso P
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Sep; 1867(9):159185. PubMed ID: 35644522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
    Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
    PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients.
    Hadarits F; Kisfali P; Mohás M; Maász A; Duga B; Janicsek I; Wittmann I; Melegh B
    Mol Biol Rep; 2012 Feb; 39(2):1949-55. PubMed ID: 21643755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin.
    Smith CE; Tucker KL; Lai CQ; Parnell LD; Lee YC; Ordovás JM
    Obesity (Silver Spring); 2010 Feb; 18(2):327-32. PubMed ID: 19629056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.